Bing Center for Waldenstrom's Macroglobulinemia

To display a list of Bing Center Newsletters, please visit our Newsletter Archive.

Articles
Title	Created Date
What It's Like to Enroll in a Clinical Trial	04 May 2015
2014 ASH Exposition and Conference	04 May 2015
Running for Waldenstrom's - Sandra Kanan	04 May 2015
Pharmacyclics Files Supplemental New Drug Application for IMBRUVICA® for Waldenstrom's Macroglobulinemia	04 May 2015
U.S. FDA Approves IMBRUVICA® (ibrutinib) for Treatment of Waldenstrom's macroglobulinemia	01 May 2015
8th International Workshop on WM	11 September 2014
Clinical Study for Carfilzomib, Dexamethasone and Rituximab (CARD) reported in BLOOD	19 May 2014
Dr. Treon presents findings from the whole genome sequencing project at the Annual Meeting of the International Waldenstrom’s Macroglobulinemia Foundation in Tampa, FL	17 May 2014
Study by the Bing Center shows Improving Survival Trends for WM	12 May 2014
Zachary Hunter and Steve Treon deliver addresses at the IWMF Canada Annual Meeting in Vancouver BC	05 April 2014
Dr. Treon addresses the Clinical Advisory Committee of the World Health Organization (WHO) in Chicago, IL	31 March 2014
National Comprehensive Cancer Network (NCCN) adds Ibrutinib to the list of therapies for WM patients with relapsed or refractory WM	08 January 2014
ASH 2013 Attendees	17 December 2013
ASH 2013 Annual Meeting and Exposition	12 December 2013
Bing Center Hosts Dutch Delegation	31 October 2013
Dr. Treon Lecture to Polish Physician's Committee	08 October 2013
Karen Lee Sobol Throws out 1st Pitch	03 October 2013
Dr Treon Lecture to New England Support Group	21 April 2013
Ibrutinib Receives FDA Breakthrough Therapy Status	14 February 2013
WM National Community	24 January 2013

Page 15 of 17